Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 16026 - 16050 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Carmustine	Approved Investigational	ATP5D	513	downregulated	Carmustine results in decreased expression of ATP5D mRNA	19p13.3	A21555
Carmustine	Approved Investigational	ATP6V0C	527	downregulated	Carmustine results in decreased expression of ATP6V0C mRNA	16p13.3	A21555
Carmustine	Approved Investigational	ATXN2L	11273	downregulated	Carmustine results in decreased expression of ATXN2L mRNA	16p11.2	A21555
Carmustine	Approved Investigational	AVPR1A	552	upregulated	Carmustine results in increased expression of AVPR1A mRNA	12q14.2	A21555
Carmustine	Approved Investigational	B4GALT5	9334	downregulated	Carmustine results in decreased expression of B4GALT5 mRNA	20q13.13	A21555
Carmustine	Approved Investigational	BAIAP2	10458	downregulated	Carmustine results in decreased expression of BAIAP2 mRNA	17q25.3	A21555
Carmustine	Approved Investigational	BAIAP3	8938	downregulated	Carmustine results in decreased expression of BAIAP3 mRNA	16p13.3	A21555
Carmustine	Approved Investigational	BCL10	8915	upregulated	Carmustine results in increased expression of BCL10 mRNA	1p22.3	A21555
Carmustine	Approved Investigational	BCL2L1	598	downregulated	Carmustine results in decreased expression of BCL2L1 mRNA	20q11.21	A21556
Carmustine	Approved Investigational	BECN1	8678	downregulated	Carmustine results in decreased expression of BECN1 mRNA	17q21.31	A21555
Carmustine	Approved Investigational	BICD1	636	downregulated	Carmustine results in decreased expression of BICD1 mRNA	12p11.21	A21555
Carmustine	Approved Investigational	BLK	640	downregulated	Carmustine results in decreased expression of BLK mRNA	8p23.1	A21555
Carmustine	Approved Investigational	BMP7	655	downregulated	Carmustine results in decreased expression of BMP7 mRNA	20q13.31	A21555
Carmustine	Approved Investigational	BRF1	2972	downregulated	Carmustine results in decreased expression of BRF1 mRNA	14q32.33	A21555
Carmustine	Approved Investigational	CA6	765	downregulated	Carmustine results in decreased expression of CA6 mRNA	1p36.23	A21555
Carmustine	Approved Investigational	CALB2	794	downregulated	Carmustine results in decreased expression of CALB2 mRNA	16q22.2	A21555
Carmustine	Approved Investigational	CCL2	6347	upregulated	Carmustine results in increased expression of CCL2 mRNA	17q12	A21555
Carmustine	Approved Investigational	CD151	977	downregulated	Carmustine results in decreased expression of CD151 mRNA	11p15.5	A21555
Carmustine	Approved Investigational	CD68	968	downregulated	Carmustine results in decreased expression of CD68 mRNA	17p13.1	A21555
Carmustine	Approved Investigational	CD79A	973	downregulated	Carmustine results in decreased expression of CD79A mRNA	19q13.2	A21555
Carmustine	Approved Investigational	CD80	941	upregulated	Carmustine results in increased expression of CD80 mRNA	3q13.33	A21555
Carmustine	Approved Investigational	CDK8	1024	downregulated	Carmustine results in decreased expression of CDK8 mRNA	13q12.13	A21555
Carmustine	Approved Investigational	CDX4	1046	downregulated	Carmustine results in decreased expression of CDX4 mRNA	Xq13.2	A21555
Carmustine	Approved Investigational	CEACAM3	1084	downregulated	Carmustine results in decreased expression of CEACAM3 mRNA	19q13.2	A21555
Carmustine	Approved Investigational	CEBPB	1051	downregulated	Carmustine results in decreased expression of CEBPB mRNA	20q13.13	A21555

Displaying entries 16026 - 16050 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability